Viagra
Pfizer ( PFE) chemists were developing a pill to treat cardiovascular ailments. In 1991 something came up (literally) that sidetracked those efforts: Test subjects exhibited a rather virile side effect to the treatment.

The pill, later named Viagra and approved by the FDA in 1998, proved a bust in terms of treating heart disease. But the unexpected benefit pumped up its maker's bottom line and set the stage for a brand-new industry.

Today, drugs to treat erectile dysfunction command more than $5 billion a year in sales globally. Of that take, Viagra accounts for about $1.9 billion, but its chief rival in the space, Eli Lilly's ( LLY) Cialis, closing in on parity.

If you liked this article you might like

The (James) Bond Market

Junk Mail Folders Can't Contain Spam Profits

Will Summer Concerts Sing the Blues?

'As Seen On TV' Rings the Till For Retailers

Praise and Profit: How Religion Pays Off